BURLINGTON, N.C. - Laboratory Corporation of America Holdings (NYSE: NYSE:LH), commonly known as Labcorp, has declared a quarterly cash dividend of $0.72 per share on its common stock. The dividend is scheduled to be paid on March 13, 2024, to shareholders who are on the record by the close of business on February 27, 2024.
Labcorp is recognized as a prominent player in the life sciences industry, providing a range of laboratory services that support physicians, hospitals, pharmaceutical entities, researchers, and patients. The company's services are designed to deliver clear insights and foster advancements in science for the enhancement of health and lives. Labcorp's operations encompass diagnostics and drug development laboratory services that contribute to the healthcare landscape.
The company is noted for its significant role in the healthcare industry, with a workforce exceeding 60,000 employees and a service reach spanning over 100 countries. According to the company's statement, Labcorp was involved in the development of over 80% of the new drugs approved by the FDA in 2022 and conducted more than 600 million tests for patients globally.
Labcorp's announcement is based on a press release statement and is intended to inform shareholders and the broader financial community of the upcoming dividend payment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.